These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 24991548)
1. Pharmacology of hallucinations: several mechanisms for one single symptom? Rolland B; Jardri R; Amad A; Thomas P; Cottencin O; Bordet R Biomed Res Int; 2014; 2014():307106. PubMed ID: 24991548 [TBL] [Abstract][Full Text] [Related]
2. Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison. Leptourgos P; Fortier-Davy M; Carhart-Harris R; Corlett PR; Dupuis D; Halberstadt AL; Kometer M; Kozakova E; LarØi F; Noorani TN; Preller KH; Waters F; Zaytseva Y; Jardri R Schizophr Bull; 2020 Dec; 46(6):1396-1408. PubMed ID: 32944778 [TBL] [Abstract][Full Text] [Related]
4. Preclinical characterization of toluene as a non-classical hallucinogen drug in rats: participation of 5-HT, dopamine and glutamate systems. Rivera-García MT; López-Rubalcava C; Cruz SL Psychopharmacology (Berl); 2015 Oct; 232(20):3797-808. PubMed ID: 26255180 [TBL] [Abstract][Full Text] [Related]
5. PDE Inhibitors for the Treatment of Schizophrenia. Snyder GL; Vanover KE Adv Neurobiol; 2017; 17():385-409. PubMed ID: 28956340 [TBL] [Abstract][Full Text] [Related]
6. Limbic circuits and monoamine receptors: dissecting the effects of antipsychotics from disease processes. Joyce JN; Goldsmith SG; Gurevich EV J Psychiatr Res; 1997; 31(2):197-217. PubMed ID: 9278186 [TBL] [Abstract][Full Text] [Related]
7. Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain? Marek GJ; Behl B; Bespalov AY; Gross G; Lee Y; Schoemaker H Mol Pharmacol; 2010 Mar; 77(3):317-26. PubMed ID: 19933774 [TBL] [Abstract][Full Text] [Related]
8. SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D Dedic N; Jones PG; Hopkins SC; Lew R; Shao L; Campbell JE; Spear KL; Large TH; Campbell UC; Hanania T; Leahy E; Koblan KS J Pharmacol Exp Ther; 2019 Oct; 371(1):1-14. PubMed ID: 31371483 [TBL] [Abstract][Full Text] [Related]
9. An animal model of schizophrenia based on chronic LSD administration: old idea, new results. Marona-Lewicka D; Nichols CD; Nichols DE Neuropharmacology; 2011 Sep; 61(3):503-12. PubMed ID: 21352832 [TBL] [Abstract][Full Text] [Related]
10. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002 [TBL] [Abstract][Full Text] [Related]
11. Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives. Pallavicini C; Vilas MG; Villarreal M; Zamberlan F; Muthukumaraswamy S; Nutt D; Carhart-Harris R; Tagliazucchi E Neuroimage; 2019 Oct; 200():281-291. PubMed ID: 31247301 [TBL] [Abstract][Full Text] [Related]
12. Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization. Wang M; Pei L; Fletcher PJ; Kapur S; Seeman P; Liu F Mol Brain; 2010 Sep; 3():25. PubMed ID: 20813060 [TBL] [Abstract][Full Text] [Related]
13. Schizophrenia: from dopaminergic to glutamatergic interventions. Laruelle M Curr Opin Pharmacol; 2014 Feb; 14():97-102. PubMed ID: 24524997 [TBL] [Abstract][Full Text] [Related]
14. Balanced NMDA receptor activity in dopamine D1 receptor (D1R)- and D2R-expressing medium spiny neurons is required for amphetamine sensitization. Beutler LR; Wanat MJ; Quintana A; Sanz E; Bamford NS; Zweifel LS; Palmiter RD Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4206-11. PubMed ID: 21368124 [TBL] [Abstract][Full Text] [Related]
15. Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia. Greene R Hippocampus; 2001; 11(5):569-77. PubMed ID: 11732709 [TBL] [Abstract][Full Text] [Related]
16. Circadian patterns of hallucinatory experiences in patients with schizophrenia: Potentials for chrono-pharmacology. Koizumi T; Suzuki T; Pillai NS; Bies RR; Takeuchi H; Yoshimura K; Mimura M; Uchida H J Psychiatr Res; 2019 Oct; 117():1-6. PubMed ID: 31254838 [TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 Receptors Modulate Pyramidal Neurons in Mouse Medial Prefrontal Cortex through a Stimulatory G-Protein Pathway. Robinson SE; Sohal VS J Neurosci; 2017 Oct; 37(42):10063-10073. PubMed ID: 28912160 [TBL] [Abstract][Full Text] [Related]